Biologics coordinators help patients access crucial medications.
At the 2022 Healthcare Advocate Summit, Heather Sawrey, Biologic Coordinator for George Washington University Department of Dermatology and president and co-founder of Biologic Coordinators of Dermatology, shared her insights into biologics access in today’s insurance landscape.
“We quickly learn that being an advocate is a labor of love; it’s not really a job we can be in and not love what we do,” Sawrey said of her work as an advocate, where she supports 11 providers at her current practice.
“We know that accessing biologics—or any drug—for your patient can be tough, exhausting frustrating, and even maddening,” she said. “But we know that when we help our patients and they get better, it is worth every single bit of work that we do for that patient.”
Advocates who work directly with patients and medical staff provide critical insights crucial to improving the patient journey. The Healthcare Advocate Summit fills a gap for advocates, creating a space where advocate voices drive conversations around solutions for medication access issues faced in the health care industry.
Full sessions from the 2022 Healthcare Advocate Summit are available to purchase on demand. To learn more about the 2023 Healthcare Advocate Summit, taking place September 6 to 8, 2023 in New Orlans, Louisiana, visit healthcareadvocatesummit.com.
FDA Accepts sNDA for Tapinarof Cream 1% for Treatment of Atopic Dermatitis
April 29th 2024The ADORING 3 phase 3 development program is currently studying the novel, aryl hydrocarbon receptor agonist as a once-daily, cosmetically elegant, and steroid-free topical cream for adults and children with atopic dermatitis.
Examining the State of Benzoyl Peroxide-Containing Acne Products After Benzene Contamination
April 10th 2024Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.
FDA Accepts sNDA for Tapinarof Cream 1% for Treatment of Atopic Dermatitis
April 29th 2024The ADORING 3 phase 3 development program is currently studying the novel, aryl hydrocarbon receptor agonist as a once-daily, cosmetically elegant, and steroid-free topical cream for adults and children with atopic dermatitis.
Examining the State of Benzoyl Peroxide-Containing Acne Products After Benzene Contamination
April 10th 2024Christopher Bunick, MD, PhD, FAAD, an associate professor of dermatology and a physician-scientist at the Yale School of Medicine in New Haven, Connecticut, presented updates on benzene in BPO at the 2024 American Academy of Dermatology Annual Meeting.
2 Commerce Drive
Cranbury, NJ 08512